CardioLogs

Cardiologs is a clinical decision support system (CDSS), and it’s designed to help physicians detect anomalies in a patient’s heart activity. Though it primarily focuses on detecting atrial fibrillation - a condition which affects around 33 million people globally - Cardiologs is highly scalable, and already capable of spotting more than 100 different kinds of cardiac abnormalities. Already, then, it is improving on the traditional industry and creating major advantages in terms of speed, cost, and accuracy of diagnostics.

A big challenge for Cardiologs could come from the popular consumer market: cardiac monitoring is almost a standard feature of modern wearables like the Apple Watch, and it is only getting better. That being said, clinical studies have proven that Cardiolog's deep learning AI greatly outperforms its counterparts, meaning that, at least for now, Cardiologs has a strong hold on the market.

Using the considerable funding it has attracted, Cardiologs plans to double down on growth in North America and Europe, and also intends to develop new integrations and applications for its technology.